0001600620-24-000035.txt : 20240307
0001600620-24-000035.hdr.sgml : 20240307
20240307164246
ACCESSION NUMBER: 0001600620-24-000035
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240306
FILED AS OF DATE: 20240307
DATE AS OF CHANGE: 20240307
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Habig Scott Michael
CENTRAL INDEX KEY: 0001938159
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36421
FILM NUMBER: 24730818
MAIL ADDRESS:
STREET 1: #1203-4464 MARKHAM STREET
CITY: VICTORIA
STATE: A1
ZIP: V8Z7X8
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Aurinia Pharmaceuticals Inc.
CENTRAL INDEX KEY: 0001600620
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 981231763
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: #140, 14315 - 118 AVENUE
CITY: EDMONTON
STATE: A0
ZIP: T5L 4S6
BUSINESS PHONE: 250-744-2487
MAIL ADDRESS:
STREET 1: #140, 14315 - 118 AVENUE
CITY: EDMONTON
STATE: A0
ZIP: T5L 4S6
4
1
wk-form4_1709847750.xml
FORM 4
X0508
4
2024-03-06
0
0001600620
Aurinia Pharmaceuticals Inc.
AUPH
0001938159
Habig Scott Michael
#140, 14315-118 AVENUE
EDMONTON
A0
T5L 4S6
ALBERTA, CANADA
0
1
0
0
Chief Commercial Officer
0
Common Stock
2024-03-06
4
S
0
17777
5.60
D
474587
D
Represents the number of shares automatically sold to cover tax withholding obligations in connection with the vesting of Restricted Stock Units related to the March 2, 2023 grant.
The price in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.475 to $5.755, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
/s/ Scott Habig
2024-03-07